Skip to content
NCRI logo alt test Toggle Menu

Main Navigation

  • About us
    • Overview
    • Our Partners
    • Our Team
    • Our Trustees
    • Our Strategy
    • Jobs and Opportunities
  • How We Work
    • NCRI Groups
    • NCRI Networks
    • Proposal Guidance
    • Clinical Trials Units
    • Patients and Carers
    • Early Career Researchers
    • Cancer Research Database
  • Areas of Interest
    • Cancer and Covid-19
    • Health Data and AI
    • Immunotherapy and Immunology
    • Living with and Beyond Cancer
    • Pathology
    • Prevention and Early Diagnosis
    • Radiotherapy
  • News and Events
    • News
    • Events
    • Reports and Publications
Newsletter sign up

WP Post Author

Laura Chambers

Laura is a Research Groups Manager. She is responsible for the Haem Onc, Lymphoma, Pathology, Prostate and Sarcoma Groups, as well as managing the groups’ governance structure and the NCRI CTU Group. She supports the Groups to develop their strategic priorities and deliver against them as well as ensuring the activities of the Groups align with the NCRI Strategy.

See author's posts

Precision medicine requires next-generation pathology

27 September 2021

New treatments require clinical trials with human participants. The SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) statement1 provides evidence-based…

Read More

Reviewing guidance for pathology parameters to improve trial quality

27 April 2021

SPIRIT-Path is a project to develop international consensus guidance on the inclusion of pathology in clinical trial protocols. NCRI’s Cellular…

Read More

With its new chair, Professor David Harrison, at the helm, CM-Path share top priorities

20 November 2019

NCRI’s Cellular Molecular Pathology Initiative (CM-Path) was established in 2016 to bring together experts from pathology and other fields to…

Read More

Professor David Harrison appointed CM-Path Chair

14 August 2019

The NCRI are pleased to announce that Professor David Harrison has been appointed to the CM-Path Chair position as of…

Read More

Interview with Dr Karin Oien, Chair of CM-Path

08 March 2019

Dr Karin Oien, Clinical Senior Lecturer in Pathology at the Institute of Cancer Sciences, University of Glasgow and recently appointed…

Read More

CM-Path at the NCRI Conference – Translational Research

06 December 2018

Report from the NCRI Conference Best of Translational Science; Pancreatic research Author: Hayley Morris, CM-Path Workstream 1 member During this…

Read More

CM-Path at the NCRI Conference – Digital Pathology

06 December 2018

Find out about what CM-Path members heard and the activities they took part in over the NCRI conference 2018 in…

Read More

CM-Path at the NCRI Conference – Biobanking

06 December 2018

Find out about what CM-Path members heard and the activities they took part in over the NCRI conference 2018 in…

Read More

CM-Path publishes Tissue Access Paper in JCPath

26 October 2018

Through my own experiences as a trainee academic pathologist, I have become aware of the rich tissue resources stored within…

Read More

Read the CM-Path consensus statement on ‘What is the role of pathologists in the implementation of liquid biopsy technologies?’

05 July 2018

CM-Path Discovery workstream held ‘The Liquid Biopsy’ Symposium on March 8th 2018. Following the day members of CM-Path worked in…

Read More

The CM-Path Biobanking Sample Quality Improvement Tool is now live!

17 May 2018

We are excited to announce that the CM-Path Biobanking Sample Quality Improvement Tool is now available for download from our…

Read More

Digital pathology – time to get serious

30 January 2018

Dr Bethany Williams – Digital Pathology Fellow, Lead for Clinical Training and Validation, Leeds Digital Pathology Project, Leeds Teaching Hospitals…

Read More

Posts navigation

  • 1
  • 2
  • 3
  • »

National Cancer Research Institute (NCRI)

2 Redman Place London E20 1JQ
T: +44 (0)20 3469 8798
E: info@ncri.org.uk

NCRI is a Charitable Incorporated Organisation (registered charity number: 1160609)

  • Terms and Conditions
  • Privacy Policy
  • Newsletter